semaglutide category Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial Effects of Once-Weekly Semaglutide on
Description
The TRIUMPH 4 phase 3 trial reported a 28.7 percent average body weight loss at 68 weeks
10.1016/j.chom.2023.03.020 57 Reis-BarbosaP
And our gut microbiome is associated with the health of every other body system: blood sugar management, hormone regulation, mood, you know, immunity
Results that last
Some are short-acting (requiring daily administration), whilst others are long-acting formulations given once weekly
It is currently only accessible through regulated clinical trials
